- Report
- January 2025
- 209 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- August 2025
- 150 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- August 2025
- 150 Pages
Global
From €2832EUR$3,160USD£2,430GBP
€3540EUR$3,950USD£3,037GBP
- Report
- August 2024
- 110 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- March 2026
- 150 Pages
Canada
From €4347EUR$4,850USD£3,729GBP
- Report
- March 2026
- 180 Pages
China
From €4347EUR$4,850USD£3,729GBP
- Report
- March 2026
- 214 Pages
Germany
From €4347EUR$4,850USD£3,729GBP
- Report
- March 2026
- 248 Pages
India
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
Canada
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
China
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
Germany
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
India
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
Canada
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
China
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 150 Pages
India
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 173 Pages
Canada
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 182 Pages
China
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 174 Pages
Germany
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 175 Pages
India
From €4347EUR$4,850USD£3,729GBP
- Report
- February 2026
- 178 Pages
Japan
From €4347EUR$4,850USD£3,729GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more